Grail (GRAL) Research & Development (2023 - 2026)
Grail's (GRAL) quarterly Research & Development came in at $47.4 million in Q2 2026, up 1.72% on a YoY basis from $46.6 million in Q2 2025, and down 1.23% quarter-over-quarter from $48.0 million in Q1 2026.
Analysis
Grail (GRAL) Research & Development (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Research & Development for 4 consecutive years, with $47.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Research & Development rose 1.72% year-over-year to $47.4 million; the trailing twelve-month figure through Jun 2026 stood at $190.7 million (down 15.91% YoY), and the FY2025 full-year result was $195.8 million, down 39.27% from the prior year.
- Research & Development retreated to $47.4 million in Q2 2026 per GRAL's latest filing, from $48.0 million in the prior quarter.
- Across five years, Research & Development topped out at $323.2 million in Q4 2023 and bottomed at $36.6 million in Q4 2023.
- Historically, Research & Development has averaged $80.6 million across 4 years, with a median of $48.5 million in 2024.
- The widest YoY moves for Research & Development: up 131.23% in 2024, down 85.05% in 2024.
- Over 4 years, Research & Development stood at $323.2 million in 2023, then tumbled by 85.05% to $48.3 million in 2024, then advanced by 0.66% to $48.6 million in 2025, then slipped by 2.5% to $47.4 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $47.4 million, $48.0 million, and $48.6 million for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 228.07 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | - |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 189.95 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 52.64 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 53.76 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 17.32 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 26.41 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 47.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.43 Mn |
| Mar 31, 2026 | 48.02 Mn |
| Sep 30, 2025 | 48.65 Mn |
| Jun 30, 2025 | 46.63 Mn |
| Mar 31, 2025 | 53.63 Mn |
| Dec 31, 2024 | 48.33 Mn |
| Sep 30, 2024 | 78.23 Mn |
| Jun 30, 2024 | 94.20 Mn |
| Mar 31, 2024 | 101.63 Mn |
| Dec 31, 2023 | 323.24 Mn |
| Oct 1, 2023 | 36.60 Mn |
| Jun 30, 2023 | 40.74 Mn |